You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
華蘭生物(002007.SZ):流感疫苗具有一定的季節性,主要在下半年接種
格隆匯 05-06 16:57

格隆匯5月6日丨有投資者在投資者互動平台向華蘭生物(002007.SZ)提問,“作為中國最大的流感疫苗生產企業,為什麼每年一季度沒有生產批籤?難道非要等世界衞生組織的流感預測嗎?他們的預測如果跟實際流行的毒株不同怎麼辦呢?作為原材料的雞蛋儲備量夠一億的產能嗎?一億的產能每年生產2000萬都銷售不出去是不是過剩了。今年流感疫苗生產計劃多少量?狂犬疫苗生產計劃多少量?”

華蘭生物回覆稱,流感疫苗具有一定的季節性,一般在上半年生產,主要在下半年接種。2023年預計會有狂犬疫苗的生產和銷售。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account